Pennsylvania

Overview

Pennsylvania legalized medical cannabis on April 17, 2016 when Governor Tom Wolf signed Senate Bill 3 (Act 16 of 2016), codified at 35 P.S. §§ 10231.101 – 10231.2110. The state became the 24th jurisdiction with a medical cannabis law. First licensed sales began February 15, 2018.

Adult-use cannabis remains illegal statewide. Several Pennsylvania cities (Philadelphia, Pittsburgh, and Harrisburg among them) have municipal ordinances reducing small-amount possession to civil fines, but these do not override state law. A January 2025 statewide poll registered 68% public support for adult-use legalization. As of the 2026 session, three privately-run retail proposals (SB 120, HB 20, HB 1735) remain under committee review.

Medical program

The Pennsylvania Department of Health, Office of Medical Marijuana administers patient certification, dispensary licensing, and the state registry.

Qualifying conditions

The Act 16 framework originally listed 17 Serious Medical Conditions (SMCs); the current list, expanded via DOH rulemaking and statutory amendment, comprises 24 SMCs. The list historically has included cancer, HIV/AIDS, ALS, Parkinson's, MS, IBD, epilepsy, chronic pain, PTSD, severe anxiety, opioid use disorder, autism, Huntington's, and others. Verify the current authoritative list directly with the PA DOH before relying on any specific enumeration.

Product forms and limits

• Approved forms: flower (added in 2018; originally non-smokable only), pills, oils, topicals, tinctures, liquids, transdermal patches.
• Patient possession: up to a 30-day supply as certified by the patient's registered practitioner.
• Home cultivation: prohibited.
• Reciprocity: none. Patients must be Pennsylvania residents to register.

Patients and caregivers

• Patient minimum age: 18. Minor patients under 18 may access medical cannabis only through a designated caregiver (parent or legal guardian) with practitioner certification.
• Caregiver minimum age: 21.
• Caregivers per patient: up to 2 designated caregivers per patient.
• Caregivers per caregiver: a single caregiver may serve up to 5 patients.
• Caregiver registration: via the PA DOH Medical Marijuana Registry; criminal background check. A caregiver may not consume the patient's cannabis unless the caregiver is also a registered patient.

Recreational status

Pennsylvania prohibits recreational cannabis statewide. Possession of small amounts has been decriminalized at the municipal level in Philadelphia, Pittsburgh, Harrisburg, State College, and others, typically reducing the penalty to a $25–$100 civil fine. These local programs do not override state law and can be revoked at any time.

The 2026 legislative session has three bills under review (SB 120, HB 20, HB 1735) proposing state-licensed retail. None has advanced past committee at the time of writing.

Patient registration steps

1. Locate a Pennsylvania-approved certifying physician through the Department of Health directory. Certifying physicians must complete a four-hour DOH training course and be registered with the Office of Medical Marijuana.
2. The patient completes the patient profile in the state Medical Marijuana Registry portal, submits identity documents, and pays the $50 ID-card fee. Reduced fees apply for patients receiving PACE, SNAP, Medical Assistance, CHIP, or with WIC enrollment.
3. The certifying physician issues a certification for one of the Department of Health's 24 Serious Medical Conditions through the registry portal.
4. Approved patients receive a Pennsylvania medical-marijuana ID card valid for one year and renewable. The card authorizes purchases at any licensed Pennsylvania dispensary.

Minor patients under 18 may access medical cannabis only through a designated caregiver (parent or legal guardian) with practitioner certification. The caregiver completes a separate application and PA State Police background check.

Reciprocity and visiting patients

Pennsylvania does not extend reciprocity to any out-of-state medical-cannabis program. Patients must be Pennsylvania residents to register. Visiting medical cardholders from New Jersey, Maryland, Delaware, New York, Ohio, or West Virginia cannot purchase from Pennsylvania dispensaries and remain subject to state criminal penalties for cannabis brought across the border.

The municipal-decriminalization frameworks in Philadelphia, Pittsburgh, and Harrisburg provide some practical protection for visitors carrying small amounts within those city limits. The protection is limited to municipal-court charges; Pennsylvania State Police and county sheriffs may still charge under state law.

Employment and workplace

Pennsylvania provides moderate employment protections for registered medical-cannabis patients under Act 16:

• Patient discrimination: employers may not discriminate against an employee solely based on certified patient status.
• Safety-sensitive positions: employers may continue to enforce drug-free workplace policies for safety-sensitive roles as defined by the employer.
• Federal contractor and DOT-regulated positions: federal drug-free workplace and DOT testing rules supersede state-level protection.
• On-the-job impairment: employers retain authority to discipline employees for on-the-job impairment.
• Workers' compensation: post-incident testing positive for THC may affect benefits if impairment at the time of incident is established.

The Pennsylvania Supreme Court and Commonwealth Court have addressed Act 16 employment protections in litigation since 2019, generally upholding patient-status protection while preserving employer discretion in safety-sensitive contexts. Public-employee positions, healthcare licensing, and CDL holders face additional licensing-board exposure beyond employer discipline.

Hemp-derived intoxicants

Pennsylvania has not enacted comprehensive restrictions on hemp-derived intoxicating cannabinoids as of mid-2026. Retail availability of delta-8 THC, delta-10 THC, THC-O, and HHC products has been substantial through gas-station, vape-shop, and dedicated hemp-retailer channels. The 2025 and 2026 sessions have considered restrictions; the General Assembly has not enacted comprehensive hemp regulation.

Recent legislative and policy history

Notable developments:

• 2016: Act 16 enacted; medical-marijuana program authorized.
• 2018: first licensed sales began February 15; flower added to authorized product forms.
• 2019-2023: condition list expanded from 17 to 24 SMCs; dispensary licensing scaled up; clinical-registrant research program implemented.
• 2024-2025: continued legislative work on adult-use legalization without enactment. Governor Josh Shapiro publicly supports adult-use legalization.
• 2026: SB 120, HB 20, and HB 1735 (variations on adult-use legalization frameworks) under committee review. The pattern of public support exceeding 60% has continued.

The April 2026 federal Schedule III rescheduling order produced no immediate Pennsylvania legislative response. Adult-use legalization continues to face Senate procedural resistance despite Governor Shapiro's support.

Federal context

Federal jurisdiction layers additional exposure on federal land, federal courthouses, military installations (Naval Support Activity Mechanicsburg, Tobyhanna Army Depot, Letterkenny Army Depot, Carlisle Barracks), and interstate highways. Gettysburg National Military Park, Independence National Historical Park, Valley Forge National Historical Park, Delaware Water Gap National Recreation Area, and Allegheny National Forest fall under federal jurisdiction where cannabis prohibition applies. I-76 (PA Turnpike), I-78, I-80, I-81, I-83, I-90, I-95, and I-99 corridors see active state-patrol and federal drug-interdiction activity. Cross-border purchase patterns with New Jersey (adult-use legal), New York (adult-use legal but slower retail rollout), Ohio (adult-use legal as of 2024), and Maryland (adult-use legal as of 2023) continue to shape consumer flows.